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Referral of patients to a 
nephrologist
It is crucial to establish a trusting and co-operative 
relationship between the primary care practice/
unit and nephrologist, with easy access between 
both. Many patients with chronic kidney disease (CKD) can 
be sufficiently managed in-between infrequent nephrological 
consultations.





• a family history of kidney disease
• a clinical picture compatible with kidney disease.
In the abovementioned cases, those with the following clinical 
characteristics would require timeous referral:
• urinary abnormalities on dipstick testing
• haematuria
• proteinuria (>1+); this should be measured using a spot urine 
albumin or protein to creatinine ratio (first morning void 
preferred but not essential)
• reduced glomerular filtration rate (GFR), i.e. stage 3 - 5 CKD 
(GFR <30 - 60 mL/min) or with rapidly rising serum creatinine
• resistant hypertension, typically requiring ≥3 antihypertensive 
agents
• any noticeable or significant changes in their clinical or histological 
status. 
It is essential that all intervening blood and urine results are 
communicated to both a nephrologist and primary care practice.
Timeous referral to a nephrologist will allow:
• management of the complications of CKD, e.g. renal anaemia, 
bone mineral disease, hypertension
• preparation for the appropriate renal replacement therapy, i.e. 
transplantation v. dialysis, either peritoneal or haemodialysis
• insertion of catheters and fistulas
• exploration of funder options, e.g. state or private.
Follow-up of CKD patients in South 
Africa  
Importance of CKD follow-up 
Worldwide, CKD is believed to affect 10% of the population; so one 
could expect around 500 000 people to be affected in South Africa 
(SA).
SA has very high prevalence rates of three important diseases that 
put people at risk of CKD, i.e. hypertension, type 2 diabetes mellitus 
and HIV.
Prevention of progression of CKD is best achieved earlier than 
later.
Delay of progression to end-stage kidney disease (ESKD) is 
particularly important in a resource-limited setting such as SA, where 
access to dialysis is limited by suitability for renal transplantation, 
particularly in the state sector.
Identifying patients who need follow-up and follow-up 
strategies
Those most at risk should be screened annually by assessing GFR and 
urinary protein (this can be easily performed on spot urine protein or 




• vascular disease (coronary and peripheral)
• advanced age, especially bone pain and proteinuria in the elderly 
(myeloma is quite common)
• a family history of kidney disease
• a recurring urinary tract infection (especially in children)
• nephrotoxic drug use – non-steroidal anti-inflammatory drugs 
(NSAIDs), lithium and tenofovir.
One should consider referral to a nephrologist for an opinion in the 
following situations:        
• Proteinuria, especially >1  g/day or worsening proteinuria and/or 
persistent haematuria, as these may indicate glomerulonephritis.
• GFR <60 mL/min or GFR worsening rapidly (acutely or >5 mL/year).
• All children should be referred.
• Familial kidney diseases, e.g. polycystic kidney disease.
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Most patients can be reviewed annually, but consider more frequent 
visits/investigations in the following situations:
• When patients are ill or have to undergo surgery.
• Poor blood pressure (BP) control, provided the patient is compliant. 
Aim to maintain BP <130/80 mmHg.
• Poor control of diabetes (glycated haemoglobin (HbA1C) >8%). 
Beware of increased potency of hypoglycaemic drugs at lower 
GFR.
• GFR <30 mL/min.
• Significant comorbidities (especially cardiac disease).
Types and frequency of investigations in CKD 
• BP should be checked at each visit.
• Proteinuria and creatinine should be checked at least annually, 
but more frequently in those with glomerular disorders and 
progressive CKD.
• Renal imaging should be performed as a screening test on 
every person with CKD. It may need to be repeated to screen for 
malignancies and when a sudden decline in renal function occurs – 
to rule out obstruction.
• Haemoglobin (Hb) should be checked at least annually, but needs 
to be reviewed at least every 3 months when GFR <30  mL/min. 
In anaemic patients, it is important to check iron status before 
starting erythropoietin therapy – try to maintain Hb 11 - 12 g/dL.
• In all patients with GFR <30  mL/min it is important to 
monitor secondary hyperparathyroidism – check corrected 
serum calcium and phosphate. Check parathyroid hormone at 
least 6-monthly.
• Monitoring of serum potassium is also important in CKD patients, 
especially those on angiotensin-converting enzyme (ACE) 
inhibitors and with a lower GFR (<30 mL/min).
• Remember comorbid conditions – patients with diabetes need 
cardiovascular review, including stress and pulse rate testing, 
review of foot health and retinopathy/cataracts at least once a year; 
those with ischaemic heart disease also require cardiac review at 
least once a year.
Remember that cardiovascular mortality is high in cases of CKD.
Conservative management of CKD 
patients in SA 
Importance of management of CKD 
• CKD management is particularly important to prevent or delay 
progression to ESKD in a resource-limited setting such as SA, 
where the state will only chronically dialyse patients suitable for 
transplantation.
• Seeing patients earlier in the course of ESKD, allows better 
planning for renal replacement therapy (RRT) should the need 
arise. Patients not eligible for state dialysis programmes will have 
waiting periods for cover for RRT imposed by medical aids for up 
to 12 months. Patients may also be able to undergo transplantation 
before needing dialysis.
Aspects of management of CKD 
• Lifestyle and diet. These will be covered in the next section.
• Hypertension. Aim to achieve consistent BP <130/80 mmHg. 
Multiple drugs may be required. ACE inhibitors and angiotensin 
II receptor blockers (ARBs) are useful agents, particularly in 
proteinuric patients, but need to be used with care in the elderly 
and in those with vasculopathy and advanced CKD. Refer to 
the hypertension guideline for use of antihypertensive agents for 
multiple therapeutic purposes.[1]
• Proteinuria. There is currently little and controversial evidence 
for the use of ACE inhibitors and ARBs as agents to prevent the 
onset of albuminuria and progression of renal disease in patients 
with microalbuminuria other than in hypertensive nephrosclerosis. 
However, in diabetes or chronic non-diabetic glomerulonephritis 
with overt proteinuria evidence supports the use of ACE inhibitors 
or ARBs to prevent or delay progression of CKD. Currently, 
evidence for the combined use of these agents to delay progression 
is controversial (see results of the ONTARGET study[2]). Overall 
control of BP to at least 130/80 mmHg is perhaps the most important 
aspect of control of proteinuria, regardless of the agents used. 
Note that non-dihydropyridine calcium channel blockers such as 
verapamil also have antiproteinuric properties and act synergistically 
with ACE inhibitors or ARBs. Of considerable importance is review 
of the use of ACE inhibitors and ARBs in patients with stages 4 
and 5 CKD due to the possible production of potentially dangerous 
electrolyte charges or sudden and permanent end-stage renal failure 
(ESRF). This is of particular importance in the elderly and diabetics.
• Diabetes. In both type 1 and 2 diabetes evidence exists that good 
control (HBA1c <7%) of glucose has a beneficial effect on progression 
and prevention of CKD, particularly of other microvascular 
complications.
• Anaemia. This will be covered in more detail in the April 2015 
edition of CME. Maintenance of Hb 10 - 12.5 g/dL is optimal and 
improves quality of life. However, published evidence does not 
support the notion that control of anaemia delays progression or 
improves cardiovascular mortality. Care should be exercised with 
therapy so as not to exceed Hb 13 g/dL.
• Planning RRT. This is an often neglected area of CKD 
management. It is acceptable and ideal below a GFR 20 mL/min 
to consider and arrange access for dialysis, or ideally pre-emptive 
kidney transplantation.
• Avoidance of nephrotoxic procedures and medications. This is a 
particularly important area of CKD management. Thought should 
be given to the real risk/benefits ratio of contrast procedures. 
Patients should be educated to discuss the advisability of continuing 
medications such as diuretics, certain antihypertensives and 
metformin with their doctors when they are ill or have to undergo 
surgery. CKD patients need to be warned to avoid NSAIDs, certain 
combination analgesics and some herbal medications that may 
lead to acute renal failure.
Modification of lifestyle and diet for 
CKD patients in SA 
Importance of lifestyle/behaviour  
• Prevention of progression of CKD. There is good evidence that 
practices such as smoking can accelerate progression to ESKD. 
Obesity may induce renal disease and/or diabetes.
• Prevention of cardiovascular morbidity/mortality. It is well known 
that CKD patients are at high risk of cardiovascular disease, which 
is exacerbated by being centrally obese, smoking or having poor 
control of diabetes and hypertension.
• Eligibility for RRT. This is a somewhat uniquely SA issue. Severe 
obesity (body mass index (BMI) >35 kg/m2), smoking and abuse 
of substances such as alcohol, may preclude patients from state 
dialysis and transplantation programmes.
Aspects of lifestyle and diet 
• Smoking cessation is important to avoid the progression of CKD 
and the  development of cardiovascular disease.
• Ideally, keep caloric intake to 30 - 35 kcal/kg/day, although if 
overweight, reduce it to 25 kcal/kg/day.
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• In earlier stages of CKD (3 - 5) protein restriction of 0.8 g/kg/day may 
be beneficial to avoid progression of CKD. Protein restriction is not 
advisable for dialysis patients, who should eat protein 1 - 2 g/kg/day.
• Fluid intake should exceed urine output by around 500 mL/day, 
or patients can be advised to weigh themselves daily to titrate 
intake/diuretic doses/fluid restriction against their established dry 
weight. Patients with cardiac failure may need more aggressive 
fluid restriction. Patients should be cautioned to reduce diuretic 
doses when fluid losses are high, e.g. sweating in hot environments, 
gastroenteritis.
• It is unhealthy to consume more than 14 units of alcohol per week 
for males, or 7 units per week for females.
• Salt restriction helps to control thirst and maintain dry weight (and 
BP). Ideally, patients should add no salt when cooking food or to 
any food. Salt intake should be restricted to 1 - 2 g/day.
• It is advisable to keep potassium intake at 2 - 3 g/day. Foods to 
be avoided are potatoes (soaking overnight in water will remove 
potassium), dried fruits, tomatoes, bananas, nuts and sweets. It is 
best to refer patients to a dietitian to discuss their diets. 
• In terms of calcium and phosphate, patients should be advised 
to limit the intake of high calcium foods (dairy products), 
and avoid vascular and other ectopic calcification, especially 
when using calcium-containing phosphate binders. Once the 
GFR falls below ~30 mL/min, it is important that patients are 
advised to limit phosphate in the diet (e.g. bran, brown rice, 
dried beans, lentils, offal, salmon, chocolate, cola drinks and 
milk products).
RRTs – dialysis, transplantation and 
organ donation 
RRTs place a great financial burden on our healthcare system. The 
demand for dialysis and transplantation greatly outweighs the supply 
of available facilities. This is essentially why early preventive therapy 
is vitally important to delay and minimise progression of renal 
disease. 
For those with ESKD, timeous referral for assessment for 
transplantation is vital. Increased non-related living donation, related 
living donation and pre-emptive transplantation will improve quality 
of life and increase available dialysis slots to accommodate new ESKD 
patients. 
In SA there is a significant number of patients suffering from ESKD, 
especially among the African population (as a result of malignant 
hypertension). HIV infection has also increased the number of patients 
requiring RRT, as it is a cause of CKD. 
All patients suffering from ESKD should be considered for RRT, 
which includes:  
• peritoneal dialysis
• automated peritoneal dialysis 
• haemodialysis 
• renal transplantation. 
Dialysis
There are few contraindications to dialysis, the main concern usually 
being quality of life and survival. Patients with the following chronic 
illnesses will probably not benefit from dialysis, as mortality will be 
high: 
• severe cardiomyopathy with refractory cardiac failure 
• advanced liver cirrhosis 
• disseminated, terminal malignancy
• end-stage chronic obstructive pulmonary disease  
• severe dementia 
• debilitating cerebrovascular accident. 
Regrettably, in SA, financial constraints often play an important 
role in determining the availability of dialysis. We should endeavour 
to offer all our patients appropriate RRT, as the alternative is 
unthinkable. Nevertheless, currently probably only about 10% of 
those who would benefit from dialysis are receiving this therapy. In 
the past 10 years, the economy of SA has grown and the availability 
of dialysis centres should likewise have improved. This is, however, 
questionable but nonetheless all patients with ESKD should at least 
be referred to a renal facility for assessment.
Transplantation and renal donation 
The number of patients awaiting renal transplantation has increased 
over time. The waiting time has increased owing to widening of the 
gap between allograft supply and demand. 
There is an urgent need to increase the donor pool, potentially 
from: 
• deceased donors 
• living related donors 
• living non-related donors. 
All provinces have organ transplant co-ordinators who should 
be contacted for all potential deceased donors. A complete list of 
co-ordinators is available from the Organ Donor Foundation (ODF), 
telephone number 0800226611, or after hours emergency number 
0847419484. The ODF website can also be visited at www.odf.org.za. We 
should all try to encourage an increase in living kidney donation despite 
cultural misconceptions. This will entail educating and increasing 
awareness of organ donation in our communities. Potential living 
donors can contact the National Kidney Foundation of SA (NKFSA) 
for more information by sending an e-mail to nkfsa@mweb.co.za.
SA has led the world in transplanting deceased HIV-positive donors to 
HIV-positive recipients, with good preliminary results. This programme 
has already transplanted a growing number of patients under the 
leadership of Dr Elmi Muller at Groote Schuur Hospital, Cape Town, SA.
Living-related allograft recipients enjoy a significant graft survival 
advantage over those who receive deceased donor graft. Living donor 
transplant has the advantage of being performed with minimum delay. 
Pre-emptive transplant (transplantation prior to dialysis) is possible. 
Evaluation of a living donor would entail: 
• compatible donor and recipient blood group
• cross-match between the individuals
• human leukocyte antigen 
• typing. 
If compatible, the donor is to be scheduled for further evaluation. 
Contraindications to donation: 
• proteinuria/haematuria 
• moderately abnormal urological anatomy
• active infection 
• chronic active viral infection (hepatitis B or C and/or HIV)
• active malignancy 
• history of malignancy – lung, breast, renal, gastrointestinal, 
haematological, melanoma 
• chronic illness, or cardiac, pulmonary, liver, autoimmune, 
neurological ilnesses
• family history of renal cell cancer 
• diabetes mellitus 
• significant hypertension 
• nephrocalcinosis and bilateral or recurrent kidney stones
• poorly controlled psychosis 
• substance abuse 
• pregnancy. 
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Donor nephrectomy 
Although 50% of functioning renal mass is removed, post-nephrectomy-
compensating hypertrophy in the remaining normal kidney returns the 
GFR to approximately 70% of baseline at 10 - 14 days. 
Long-term follow-up studies have not shown progressive loss of 
GFR over time. 
Donor survival was similar to that of the general population 
matched for age, sex and race. The rate of ESKD in the donor group 
was lower than that among the general population. 
Laparoscopic donor nephrectomy is performed in some transplant 
centres in SA, which  may shorten hospital stay for the donor. 
Female donor 
A female donor of child-bearing age should have completed any 
plans for a family prior to considering kidney donation. There is 
an increased risk for fetal loss, gestational diabetes, gestational 
hypertension and pre-eclampsia during pregnancy after kidney 
donation than in pregnancy in non-donors. 
N.B.: Organ trading and organ donation involving any financial 
transaction between donor and recipient are illegal in SA. 
Evaluation of potential renal transplant recipient 
Kidney transplantation is the treatment of choice for ESKD, although 
there is growing evidence that the dialysis survival rate in SA is higher 
than in most other countries. Successful kidney transplantation 
improves the quality of life of most patients compared with dialysis. 
Contraindications:
• untreated infection 
• malignancy with short life expectancy 
• chronic illness with life expectancy <1 year
• poorly controlled psychosis 
• active substance abuse. 
All other patients should be assessed and evaluated by the transplant 
team to ascertain age suitability for transplantation. Age is no longer 
considered a contraindication to transplantation. Many patients >60 
years of age have been transplanted safely. Assessment will focus on 
fitness of the patient to undergo surgery. 
Renal diagnosis 
The type of original kidney disease is not a contraindication to 
transplantation. Although many diseases recur in the allograft and 
occasionally lead to graft failure, e.g. focal segmental hyalinosis and 
IgA nephropathy, no disease recurrence is so common as to preclude 
a patient from transplant. 
Renal function 
There are recommendations for adult candidates for placement on 
the transplant list when the GFR is <18  mL/min with progressive 
renal disease. 
Nephrectomy
Pre-transplant nephrectomy of a potential recipient is not 
recommended. The only exception is autosomal polycystic kidney 
disease, which may require nephrectomy owing to recurrent 
symptomatic cyst-related complications or a very large size cystic 
kidney that makes transplant surgery difficult. 
Coronary artery disease (CAD) 
All patients with a high risk for CAD (especially diabetics) usually 
have a full cardiac assessment by a cardiologist prior to consideration 
for listing. Cardiovascular disease is the leading cause of death after 
kidney transplantation. 
Cerebrovascular disease 
Older patients and patients with risk factors will be evaluated with 
carotid Doppler to exclude carotid stenosis. All patients who have had 
a transient ischaemic attack need to be evaluated fully by a neurologist.
Obesity
Extremely obese patients (BMI >35 - 40  kg/m2) are excluded from 
transplantation, unless significant weight loss is achieved. 
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